Can a patient with primary syphilis be treated with co-amoxiclav (amoxicillin/clavulanic acid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Co-Amoxiclav is NOT Appropriate for Primary Syphilis Treatment

Co-amoxiclav (amoxicillin/clavulanic acid) should not be used to treat primary syphilis—benzathine penicillin G 2.4 million units IM as a single dose remains the only recommended first-line treatment. 1

Why Co-Amoxiclav Fails as Syphilis Treatment

The critical issue is that clavulanic acid provides no benefit for treating Treponema pallidum, and the standard co-amoxiclav formulations do not deliver adequate amoxicillin dosing for syphilis treatment. 2, 1

  • Benzathine penicillin G is the gold standard for all stages of syphilis, with documented efficacy showing 100% clinical cure and seronegativity within one year for primary syphilis. 2, 1, 3, 4

  • The only scenario where oral amoxicillin has shown efficacy is when combined with probenecid (not clavulanic acid) at high doses—specifically 3 grams daily of amoxicillin with probenecid for 10-14 days. 5, 6

The Evidence for Amoxicillin (When Done Correctly)

While amoxicillin alone has been studied as an alternative, it requires specific conditions that co-amoxiclav does not meet:

  • A randomized trial demonstrated that amoxicillin 500 mg four times daily (2 grams/day total) plus probenecid for 10 days showed comparable efficacy to benzathine penicillin G, though this was used as enhanced therapy alongside benzathine penicillin. 5

  • Recent data suggest even shorter courses (5-11 days) of 3 grams daily amoxicillin with probenecid may be effective in HIV-infected patients, though this remains investigational. 6

  • The probenecid is essential because it blocks renal excretion of penicillin, maintaining adequate serum levels—clavulanic acid does not provide this pharmacokinetic benefit. 5

Recommended Treatment Algorithm

For non-pregnant, non-allergic patients:

  • Benzathine penicillin G 2.4 million units IM as a single dose. 2, 1

For penicillin-allergic, non-pregnant patients:

  • Doxycycline 100 mg orally twice daily for 14 days is the recommended alternative. 2, 1
  • Tetracycline 500 mg orally four times daily for 14 days is a second alternative. 2, 1

For pregnant patients with penicillin allergy:

  • Mandatory penicillin desensitization followed by benzathine penicillin G—no oral alternatives are acceptable as only penicillin prevents congenital syphilis. 1

Critical Pitfalls to Avoid

  • Do not use oral penicillin preparations (including co-amoxiclav) as they are ineffective for syphilis treatment. 1

  • Do not use azithromycin in the United States due to widespread macrolide resistance and documented treatment failures. 1

  • If considering amoxicillin as an alternative (in settings with benzathine penicillin shortages), it must be high-dose amoxicillin with probenecid, not co-amoxiclav. 5, 6

  • Ceftriaxone 1 gram IM/IV daily for 10-14 days is a reasonable alternative based on randomized trial data, but remains second-line. 1

Follow-Up Requirements

  • All patients with syphilis should be tested for HIV. 1, 7

  • Clinical and serologic follow-up at 3 and 6 months for HIV-negative patients; at 3,6,9,12, and 24 months for HIV-positive patients. 1, 8, 7

  • Treatment success is defined as a fourfold decline in nontreponemal test titers within 6 months for primary syphilis. 1, 8

References

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of primary and secondary syphilis: serologic response.

Journal of the American Academy of Dermatology, 1986

Guideline

Syphilis Treatment in Patients with HIV

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Retesting After Syphilis Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.